High titers of infectious SARS-CoV-2 in corpses of patients with COVID-19

•Infectious SARS-CoV-2 remained in 55% (6/11) corpses and 43% (13/30) specimens.•The highest infectious titer was 2.09E + 06 plaque-forming units/g in corpse lung tissue.•The time from death to discovery was 0-1 day in all cases with the infectious virus.•The longest postmortem interval with virus i...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of infectious diseases Vol. 129; pp. 103 - 109
Main Authors Saitoh, Hisako, Sakai-Tagawa, Yuko, Nagasawa, Sayaka, Torimitsu, Suguru, Kubota, Kazumi, Hirata, Yuichiro, Iwatsuki-Horimoto, Kiyoko, Motomura, Ayumi, Ishii, Namiko, Okaba, Keisuke, Horioka, Kie, Abe, Hiroyuki, Ikemura, Masako, Rokutan, Hirofumi, Hinata, Munetoshi, Iwasaki, Akiko, Yasunaga, Yoichi, Nakajima, Makoto, Yamaguchi, Rutsuko, Tsuneya, Shigeki, Kira, Kei, Kobayashi, Susumu, Inokuchi, Go, Chiba, Fumiko, Hoshioka, Yumi, Mori, Aika, Yamamoto, Isao, Nakagawa, Kimiko, Katano, Harutaka, Iida, Shun, Suzuki, Tadaki, Akitomi, Shinji, Hasegawa, Iwao, Ushiku, Tetsuo, Yajima, Daisuke, Iwase, Hirotaro, Makino, Yohsuke, Kawaoka, Yoshihiro
Format Journal Article
LanguageEnglish
Published Canada Elsevier Ltd 01.04.2023
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract •Infectious SARS-CoV-2 remained in 55% (6/11) corpses and 43% (13/30) specimens.•The highest infectious titer was 2.09E + 06 plaque-forming units/g in corpse lung tissue.•The time from death to discovery was 0-1 day in all cases with the infectious virus.•The longest postmortem interval with virus infectivity was 13 days (12 days refrigerated).•The status of the corpse influences SARS-CoV-2 infectivity. The prolonged presence of infectious SARS-CoV-2 in deceased patients with COVID-19 has been reported. However, infectious virus titers have not been determined. Such information is important for public health, death investigation, and handling corpses. The aim of this study was to assess the level of SARS-CoV-2 infectivity in the corpses of patients with COVID-19. We collected 11 nasopharyngeal swabs and 19 lung tissue specimens from 11 autopsy cases with COVID-19 in 2021. We then investigated the viral genomic copy number by real-time reverse transcription-polymerase chain reaction and infectious titers by cell culture and virus isolation. Infectious virus was present in six of 11 (55%) cases, four of 11 (36%) nasopharyngeal swabs, and nine of 19 (47%) lung specimens. The virus titers ranged from 6.00E + 01 plaque-forming units/ml to 2.09E + 06 plaque-forming units/g. In all cases in which an infectious virus was found, the time from death to discovery was within 1 day and the longest postmortem interval was 13 days. The corpses of patients with COVID-19 may have high titers of infectious virus after a long postmortem interval (up to 13 days). Therefore, appropriate infection control measures must be taken when handling corpses.
AbstractList Objectives: The prolonged presence of infectious SARS-CoV-2 in deceased patients with COVID-19 has been reported. However, infectious virus titers have not been determined. Such information is important for public health, death investigation, and handling corpses. The aim of this study was to assess the level of SARS-CoV-2 infectivity in the corpses of patients with COVID-19. Methods: We collected 11 nasopharyngeal swabs and 19 lung tissue specimens from 11 autopsy cases with COVID-19 in 2021. We then investigated the viral genomic copy number by real-time reverse transcription-polymerase chain reaction and infectious titers by cell culture and virus isolation. Results: Infectious virus was present in six of 11 (55%) cases, four of 11 (36%) nasopharyngeal swabs, and nine of 19 (47%) lung specimens. The virus titers ranged from 6.00E + 01 plaque-forming units/ml to 2.09E + 06 plaque-forming units/g. In all cases in which an infectious virus was found, the time from death to discovery was within 1 day and the longest postmortem interval was 13 days. Conclusion: The corpses of patients with COVID-19 may have high titers of infectious virus after a long postmortem interval (up to 13 days). Therefore, appropriate infection control measures must be taken when handling corpses.
•Infectious SARS-CoV-2 remained in 55% (6/11) corpses and 43% (13/30) specimens.•The highest infectious titer was 2.09E + 06 plaque-forming units/g in corpse lung tissue.•The time from death to discovery was 0-1 day in all cases with the infectious virus.•The longest postmortem interval with virus infectivity was 13 days (12 days refrigerated).•The status of the corpse influences SARS-CoV-2 infectivity. The prolonged presence of infectious SARS-CoV-2 in deceased patients with COVID-19 has been reported. However, infectious virus titers have not been determined. Such information is important for public health, death investigation, and handling corpses. The aim of this study was to assess the level of SARS-CoV-2 infectivity in the corpses of patients with COVID-19. We collected 11 nasopharyngeal swabs and 19 lung tissue specimens from 11 autopsy cases with COVID-19 in 2021. We then investigated the viral genomic copy number by real-time reverse transcription-polymerase chain reaction and infectious titers by cell culture and virus isolation. Infectious virus was present in six of 11 (55%) cases, four of 11 (36%) nasopharyngeal swabs, and nine of 19 (47%) lung specimens. The virus titers ranged from 6.00E + 01 plaque-forming units/ml to 2.09E + 06 plaque-forming units/g. In all cases in which an infectious virus was found, the time from death to discovery was within 1 day and the longest postmortem interval was 13 days. The corpses of patients with COVID-19 may have high titers of infectious virus after a long postmortem interval (up to 13 days). Therefore, appropriate infection control measures must be taken when handling corpses.
The prolonged presence of infectious SARS-CoV-2 in deceased patients with COVID-19 has been reported. However, infectious virus titers have not been determined. Such information is important for public health, death investigation, and handling corpses. The aim of this study was to assess the level of SARS-CoV-2 infectivity in the corpses of patients with COVID-19.OBJECTIVESThe prolonged presence of infectious SARS-CoV-2 in deceased patients with COVID-19 has been reported. However, infectious virus titers have not been determined. Such information is important for public health, death investigation, and handling corpses. The aim of this study was to assess the level of SARS-CoV-2 infectivity in the corpses of patients with COVID-19.We collected 11 nasopharyngeal swabs and 19 lung tissue specimens from 11 autopsy cases with COVID-19 in 2021. We then investigated the viral genomic copy number by real-time reverse transcription-polymerase chain reaction and infectious titers by cell culture and virus isolation.METHODSWe collected 11 nasopharyngeal swabs and 19 lung tissue specimens from 11 autopsy cases with COVID-19 in 2021. We then investigated the viral genomic copy number by real-time reverse transcription-polymerase chain reaction and infectious titers by cell culture and virus isolation.Infectious virus was present in six of 11 (55%) cases, four of 11 (36%) nasopharyngeal swabs, and nine of 19 (47%) lung specimens. The virus titers ranged from 6.00E + 01 plaque-forming units/ml to 2.09E + 06 plaque-forming units/g. In all cases in which an infectious virus was found, the time from death to discovery was within 1 day and the longest postmortem interval was 13 days.RESULTSInfectious virus was present in six of 11 (55%) cases, four of 11 (36%) nasopharyngeal swabs, and nine of 19 (47%) lung specimens. The virus titers ranged from 6.00E + 01 plaque-forming units/ml to 2.09E + 06 plaque-forming units/g. In all cases in which an infectious virus was found, the time from death to discovery was within 1 day and the longest postmortem interval was 13 days.The corpses of patients with COVID-19 may have high titers of infectious virus after a long postmortem interval (up to 13 days). Therefore, appropriate infection control measures must be taken when handling corpses.CONCLUSIONThe corpses of patients with COVID-19 may have high titers of infectious virus after a long postmortem interval (up to 13 days). Therefore, appropriate infection control measures must be taken when handling corpses.
The prolonged presence of infectious SARS-CoV-2 in deceased patients with COVID-19 has been reported. However, infectious virus titers have not been determined. Such information is important for public health, death investigation, and handling corpses. The aim of this study was to assess the level of SARS-CoV-2 infectivity in the corpses of patients with COVID-19. We collected 11 nasopharyngeal swabs and 19 lung tissue specimens from 11 autopsy cases with COVID-19 in 2021. We then investigated the viral genomic copy number by real-time reverse transcription-polymerase chain reaction and infectious titers by cell culture and virus isolation. Infectious virus was present in six of 11 (55%) cases, four of 11 (36%) nasopharyngeal swabs, and nine of 19 (47%) lung specimens. The virus titers ranged from 6.00E + 01 plaque-forming units/ml to 2.09E + 06 plaque-forming units/g. In all cases in which an infectious virus was found, the time from death to discovery was within 1 day and the longest postmortem interval was 13 days. The corpses of patients with COVID-19 may have high titers of infectious virus after a long postmortem interval (up to 13 days). Therefore, appropriate infection control measures must be taken when handling corpses.
Author Iwase, Hirotaro
Rokutan, Hirofumi
Chiba, Fumiko
Kubota, Kazumi
Katano, Harutaka
Inokuchi, Go
Hoshioka, Yumi
Okaba, Keisuke
Iida, Shun
Ushiku, Tetsuo
Tsuneya, Shigeki
Hirata, Yuichiro
Yamamoto, Isao
Hasegawa, Iwao
Makino, Yohsuke
Hinata, Munetoshi
Yamaguchi, Rutsuko
Abe, Hiroyuki
Kira, Kei
Iwasaki, Akiko
Yasunaga, Yoichi
Suzuki, Tadaki
Nakajima, Makoto
Mori, Aika
Ishii, Namiko
Iwatsuki-Horimoto, Kiyoko
Horioka, Kie
Nagasawa, Sayaka
Akitomi, Shinji
Nakagawa, Kimiko
Yajima, Daisuke
Kawaoka, Yoshihiro
Motomura, Ayumi
Sakai-Tagawa, Yuko
Kobayashi, Susumu
Ikemura, Masako
Torimitsu, Suguru
Saitoh, Hisako
Author_xml – sequence: 1
  givenname: Hisako
  orcidid: 0000-0001-6297-3738
  surname: Saitoh
  fullname: Saitoh, Hisako
  email: hms1466@faculty.chiba-u.jp
  organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
– sequence: 2
  givenname: Yuko
  surname: Sakai-Tagawa
  fullname: Sakai-Tagawa, Yuko
  organization: Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
– sequence: 3
  givenname: Sayaka
  surname: Nagasawa
  fullname: Nagasawa, Sayaka
  organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
– sequence: 4
  givenname: Suguru
  orcidid: 0000-0003-4891-8673
  surname: Torimitsu
  fullname: Torimitsu, Suguru
  organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
– sequence: 5
  givenname: Kazumi
  orcidid: 0000-0003-2270-2313
  surname: Kubota
  fullname: Kubota, Kazumi
  organization: Department of Healthcare Information Management, The University of Tokyo Hospital, Tokyo, Japan
– sequence: 6
  givenname: Yuichiro
  surname: Hirata
  fullname: Hirata, Yuichiro
  organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
– sequence: 7
  givenname: Kiyoko
  surname: Iwatsuki-Horimoto
  fullname: Iwatsuki-Horimoto, Kiyoko
  organization: Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
– sequence: 8
  givenname: Ayumi
  surname: Motomura
  fullname: Motomura, Ayumi
  organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
– sequence: 9
  givenname: Namiko
  surname: Ishii
  fullname: Ishii, Namiko
  organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
– sequence: 10
  givenname: Keisuke
  surname: Okaba
  fullname: Okaba, Keisuke
  organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
– sequence: 11
  givenname: Kie
  surname: Horioka
  fullname: Horioka, Kie
  organization: Department of Legal Medicine, International University of Health and Welfare, Tokyo, Japan
– sequence: 12
  givenname: Hiroyuki
  orcidid: 0000-0003-4513-1007
  surname: Abe
  fullname: Abe, Hiroyuki
  organization: Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
– sequence: 13
  givenname: Masako
  surname: Ikemura
  fullname: Ikemura, Masako
  organization: Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
– sequence: 14
  givenname: Hirofumi
  orcidid: 0000-0003-4172-4892
  surname: Rokutan
  fullname: Rokutan, Hirofumi
  organization: Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
– sequence: 15
  givenname: Munetoshi
  surname: Hinata
  fullname: Hinata, Munetoshi
  organization: Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
– sequence: 16
  givenname: Akiko
  surname: Iwasaki
  fullname: Iwasaki, Akiko
  organization: Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
– sequence: 17
  givenname: Yoichi
  surname: Yasunaga
  fullname: Yasunaga, Yoichi
  organization: Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
– sequence: 18
  givenname: Makoto
  surname: Nakajima
  fullname: Nakajima, Makoto
  organization: Department of Forensic Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
– sequence: 19
  givenname: Rutsuko
  surname: Yamaguchi
  fullname: Yamaguchi, Rutsuko
  organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
– sequence: 20
  givenname: Shigeki
  surname: Tsuneya
  fullname: Tsuneya, Shigeki
  organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
– sequence: 21
  givenname: Kei
  orcidid: 0000-0002-9250-8420
  surname: Kira
  fullname: Kira, Kei
  organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
– sequence: 22
  givenname: Susumu
  surname: Kobayashi
  fullname: Kobayashi, Susumu
  organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
– sequence: 23
  givenname: Go
  surname: Inokuchi
  fullname: Inokuchi, Go
  organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
– sequence: 24
  givenname: Fumiko
  orcidid: 0000-0001-5636-0695
  surname: Chiba
  fullname: Chiba, Fumiko
  organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
– sequence: 25
  givenname: Yumi
  orcidid: 0000-0001-8852-6530
  surname: Hoshioka
  fullname: Hoshioka, Yumi
  organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
– sequence: 26
  givenname: Aika
  surname: Mori
  fullname: Mori, Aika
  organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
– sequence: 27
  givenname: Isao
  surname: Yamamoto
  fullname: Yamamoto, Isao
  organization: Department of Forensic Medicine, Kanagawa Dental University, Yokosuka, Japan
– sequence: 28
  givenname: Kimiko
  surname: Nakagawa
  fullname: Nakagawa, Kimiko
  organization: Department of Forensic Medicine, Kanagawa Dental University, Yokosuka, Japan
– sequence: 29
  givenname: Harutaka
  orcidid: 0000-0002-5332-4434
  surname: Katano
  fullname: Katano, Harutaka
  organization: Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan
– sequence: 30
  givenname: Shun
  orcidid: 0000-0003-2258-9031
  surname: Iida
  fullname: Iida, Shun
  organization: Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan
– sequence: 31
  givenname: Tadaki
  surname: Suzuki
  fullname: Suzuki, Tadaki
  organization: Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan
– sequence: 32
  givenname: Shinji
  surname: Akitomi
  fullname: Akitomi, Shinji
  organization: Department of Forensic Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
– sequence: 33
  givenname: Iwao
  surname: Hasegawa
  fullname: Hasegawa, Iwao
  organization: Department of Forensic Medicine, Kanagawa Dental University, Yokosuka, Japan
– sequence: 34
  givenname: Tetsuo
  surname: Ushiku
  fullname: Ushiku, Tetsuo
  organization: Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
– sequence: 35
  givenname: Daisuke
  surname: Yajima
  fullname: Yajima, Daisuke
  organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
– sequence: 36
  givenname: Hirotaro
  surname: Iwase
  fullname: Iwase, Hirotaro
  organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
– sequence: 37
  givenname: Yohsuke
  orcidid: 0000-0002-0025-5252
  surname: Makino
  fullname: Makino, Yohsuke
  organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
– sequence: 38
  givenname: Yoshihiro
  surname: Kawaoka
  fullname: Kawaoka, Yoshihiro
  organization: Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36754229$$D View this record in MEDLINE/PubMed
BookMark eNqFkU1vVCEYhYmpsR_6B1yYu3Rzr8D9AIybZqp2kiZNrHZLmJeXluudywiMpv9eptO66KKuIOQ8h-Q8x-RgDjMS8pbRhlE2fBgbP3rbcMrbhrKGdsMLcsSkkHXbM3ZQ7pyyWgnGD8lxSiOlJTLIV-SwHUTfca6OyPLc39xW2WeMqQqu8rNDyD5sU3V1-u2qXoTrmpfXCkLcJLzPbEz2OOdU_fH5tlpcXi_PaqZek5fOTAnfPJwn5MeXz98X5_XF5dfl4vSihp6JXNtBCKXAYE8d66ik3FrXrwQHULRVTqiBcVDKdtQNwjgqOQyrHiwD2inXtydkue-1wYx6E_3axDsdjNf3DyHeaBOzhwk1mrblCFxyjl0rwYAD20uAzsleuLZ0vd93bWL4tcWU9donwGkyM5YJNBeik2oYmCzRdw_R7WqN9t_Hj1OWgNwHIIaUIjoNPpelwpyj8ZNmVO-s6VHvrOmdNU2ZLkoKyp-gj-3PQp_2EJaxf3uMOkHRAmh9LArLGv55_OMTHCY_ezDTT7z7H_wXc83A_g
CitedBy_id crossref_primary_10_3390_forensicsci4040042
crossref_primary_10_3390_forensicsci5010006
crossref_primary_10_1371_journal_pone_0287068
crossref_primary_10_1002_ase_2501
crossref_primary_10_1016_j_legalmed_2024_102530
Cites_doi 10.1007/s12024-021-00379-9
10.1128/JCM.01094-20
10.3201/eid2701.203112
10.3201/eid2706.210226
10.3201/eid2801.211749
10.1038/s41598-021-98499-3
10.1016/j.jflm.2020.101999
10.1097/PAF.0000000000000779
10.1016/j.ijid.2021.03.052
10.7883/yoken.JJID.2020.061
10.1136/bmjgh-2020-002650
10.1007/s00414-021-02546-7
10.1007/s12024-021-00375-z
10.3201/eid2609.201353
10.4103/jfsm.jfsm_5_21
10.1002/jmv.21962
10.1073/pnas.2002589117
10.1007/s00414-021-02753-2
10.7554/eLife.60361
ContentType Journal Article
Copyright 2023 The Author(s)
Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Copyright_xml – notice: 2023 The Author(s)
– notice: Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOA
DOI 10.1016/j.ijid.2023.01.046
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DOAJ: Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 1878-3511
EndPage 109
ExternalDocumentID oai_doaj_org_article_ea332ec2822e438cacfcd58cc4f857f3
36754229
10_1016_j_ijid_2023_01_046
S1201971223000474
Genre Journal Article
GroupedDBID ---
--K
.1-
.FO
.~1
0R~
1B1
1P~
1~.
1~5
29J
3O-
4.4
457
4G.
53G
5GY
5VS
7-5
71M
7X7
88E
8C1
8FI
8FJ
8FQ
8R4
8R5
AAEDW
AAFWJ
AAIKJ
AALRI
AAQFI
AAQXK
AARKO
AAXUO
AAYWO
ABBQC
ABFRF
ABMAC
ABUWG
ABWVN
ACGFO
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADVLN
AEFWE
AEKER
AENEX
AEUPX
AEVXI
AEXQZ
AFJKZ
AFKRA
AFPKN
AFPUW
AFRHN
AFTJW
AGEKW
AGHFR
AGQPQ
AGYEJ
AHMBA
AIGII
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
ASPBG
AVWKF
AZFZN
BAWUL
BCNDV
BENPR
BPHCQ
BR6
BVXVI
CCPQU
CS3
DIK
DU5
DWQXO
E3Z
EBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FNPLU
FYUFA
G-Q
GBLVA
GROUPED_DOAJ
GX1
HMCUK
HVGLF
HZ~
IHE
IXB
J1W
KQ8
M1P
M3C
M3G
M41
MO0
N9A
O-L
O9-
OD-
OK1
OO.
OZT
P-8
P-9
P2P
PC.
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
Q2X
Q38
QTD
R2-
ROL
RPZ
RWL
RXW
SDF
SDG
SEL
SES
SEW
SSZ
TAE
UKHRP
UNMZH
Z5R
0SF
3V.
6I.
AACTN
AAFTH
ABVKL
AFCTW
ALIPV
NCXOZ
RIG
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c517t-d67799cae50f140802ddf5b72cc9039f79612c99d40f67af082c6b5cd1c049f53
IEDL.DBID .~1
ISSN 1201-9712
1878-3511
IngestDate Wed Aug 27 01:21:13 EDT 2025
Fri Jul 11 09:01:16 EDT 2025
Wed Feb 19 02:25:00 EST 2025
Tue Jul 01 04:30:16 EDT 2025
Thu Apr 24 23:13:24 EDT 2025
Tue Jun 18 08:52:08 EDT 2024
Tue Aug 26 16:32:02 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords COVID-19
Infectious titer
SARS-CoV-2
Postmortem interval
Autopsy
Virus isolation
Language English
License This is an open access article under the CC BY license.
Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c517t-d67799cae50f140802ddf5b72cc9039f79612c99d40f67af082c6b5cd1c049f53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-6297-3738
0000-0001-5636-0695
0000-0002-9250-8420
0000-0001-8852-6530
0000-0003-2270-2313
0000-0003-2258-9031
0000-0003-4891-8673
0000-0003-4513-1007
0000-0002-5332-4434
0000-0003-4172-4892
0000-0002-0025-5252
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S1201971223000474
PMID 36754229
PQID 2774896618
PQPubID 23479
PageCount 7
ParticipantIDs doaj_primary_oai_doaj_org_article_ea332ec2822e438cacfcd58cc4f857f3
proquest_miscellaneous_2774896618
pubmed_primary_36754229
crossref_citationtrail_10_1016_j_ijid_2023_01_046
crossref_primary_10_1016_j_ijid_2023_01_046
elsevier_sciencedirect_doi_10_1016_j_ijid_2023_01_046
elsevier_clinicalkey_doi_10_1016_j_ijid_2023_01_046
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate April 2023
2023-04-00
2023-Apr
20230401
2023-04-01
PublicationDateYYYYMMDD 2023-04-01
PublicationDate_xml – month: 04
  year: 2023
  text: April 2023
PublicationDecade 2020
PublicationPlace Canada
PublicationPlace_xml – name: Canada
PublicationTitle International journal of infectious diseases
PublicationTitleAlternate Int J Infect Dis
PublicationYear 2023
Publisher Elsevier Ltd
Elsevier
Publisher_xml – name: Elsevier Ltd
– name: Elsevier
References Shirato, Nao, Katano, Takayama, Saito, Kato (bib0012) 2020; 73
Drommi, Barranco, Balbo, Errico, Elena Frigiolini, Mangioni (bib0001) 2022; 8
Zacharias, Stangl, Thüringer, Loibner, Wurm, Wolfgruber (bib0009) 2021; 27
Heinrich, Meißner, Langenwalder, Püschel, Nörz, Hoffmann (bib0007) 2021; 27
Perchetti, Huang, Peddu, Jerome, Greninger (bib0019) 2020; 58
Fineschi, Aprile, Aquila, Arcangeli, Asmundo, Bacci (bib0016) 2020; 112
Heinrich, Schröder, Gerberding, Gerling, Langenwalder, Lange (bib0010) 2022; 28
Ventura, Drommi, Barranco, Balbo, Errico, Mangioni (bib0002) 2022; 43
Schröder, Edler, Ondruschka, Püschel, Schädler, Heinemann (bib0006) 2021; 17
Grassi, Arena, Cattani, Dell'Aquila, Liotti, Sanguinetti (bib0015) 2022; 136
2022 [accessed 27 September 2022].
Adachi, Chong, Nakajima, Sano, Yamazaki, Miyamoto (bib0011) 2020; 26
Yaacoub, Schünemann, Khabsa, El-Harakeh, Khamis, Chamseddine (bib0017) 2020; 5
2020 [accessed 27 September 2022].
Deinhardt-Emmer, Wittschieber, Sanft, Kleemann, Elschner, Haupt (bib0003) 2021; 10
Plenzig, Bojkova, Held, Berger, Holz, Cinatl (bib0008) 2021; 135
Katano, Kano, Nakamura, Kanno, Asanuma, Sata (bib0013) 2011; 83
Centers for Disease Control and Prevention. Collection and submission of postmortem specimens from deceased persons with confirmed or suspected COVID-19, postmortem guidance
Fitzek, Schädler, Dietz, Ron, Gerling, Kammal (bib0004) 2021; 11
World Health Organization. Infection prevention and control for the safe management of a dead body in the context of COVID-19: interim guidance
Matsuyama, Nao, Shirato, Kawase, Saito, Takayama (bib0014) 2020; 117
Dijkhuizen, Gelderman, Duijst (bib0020) 2020; 73
Gabbrielli, Gandolfo, Anichini, Candelori, Benvenuti, Savellini (bib0005) 2021; 106
Sablone, Solarino, Ferorelli, Benevento, Chironna, Loconsole (bib0018) 2021; 17
Matsuyama (10.1016/j.ijid.2023.01.046_bib0014) 2020; 117
Fitzek (10.1016/j.ijid.2023.01.046_bib0004) 2021; 11
Zacharias (10.1016/j.ijid.2023.01.046_bib0009) 2021; 27
Adachi (10.1016/j.ijid.2023.01.046_bib0011) 2020; 26
Ventura (10.1016/j.ijid.2023.01.046_bib0002) 2022; 43
Shirato (10.1016/j.ijid.2023.01.046_bib0012) 2020; 73
Katano (10.1016/j.ijid.2023.01.046_bib0013) 2011; 83
Yaacoub (10.1016/j.ijid.2023.01.046_bib0017) 2020; 5
Heinrich (10.1016/j.ijid.2023.01.046_bib0007) 2021; 27
Plenzig (10.1016/j.ijid.2023.01.046_bib0008) 2021; 135
Perchetti (10.1016/j.ijid.2023.01.046_bib0019) 2020; 58
Schröder (10.1016/j.ijid.2023.01.046_bib0006) 2021; 17
Sablone (10.1016/j.ijid.2023.01.046_bib0018) 2021; 17
Drommi (10.1016/j.ijid.2023.01.046_bib0001) 2022; 8
Dijkhuizen (10.1016/j.ijid.2023.01.046_bib0020) 2020; 73
Deinhardt-Emmer (10.1016/j.ijid.2023.01.046_bib0003) 2021; 10
Fineschi (10.1016/j.ijid.2023.01.046_bib0016) 2020; 112
Grassi (10.1016/j.ijid.2023.01.046_bib0015) 2022; 136
10.1016/j.ijid.2023.01.046_bib0022
Gabbrielli (10.1016/j.ijid.2023.01.046_bib0005) 2021; 106
Heinrich (10.1016/j.ijid.2023.01.046_bib0010) 2022; 28
10.1016/j.ijid.2023.01.046_bib0021
References_xml – volume: 10
  start-page: e60361
  year: 2021
  ident: bib0003
  article-title: Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage
  publication-title: eLife
– volume: 117
  start-page: 7001
  year: 2020
  end-page: 7003
  ident: bib0014
  article-title: Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
  publication-title: Proc Natl Acad Sci U S A
– volume: 83
  start-page: 322
  year: 2011
  end-page: 330
  ident: bib0013
  article-title: A novel real-time PCR system for simultaneous detection of human viruses in clinical samples from patients with uncertain diagnoses
  publication-title: J Med Virol
– volume: 136
  start-page: 935
  year: 2022
  end-page: 939
  ident: bib0015
  article-title: SARS-CoV-2 viral load and replication in postmortem examinations
  publication-title: Int J Legal Med
– volume: 135
  start-page: 2055
  year: 2021
  end-page: 2060
  ident: bib0008
  article-title: Infectivity of deceased COVID-19 patients
  publication-title: Int J Legal Med
– reference: ; 2022 [accessed 27 September 2022].
– volume: 27
  start-page: 329
  year: 2021
  end-page: 331
  ident: bib0007
  article-title: Postmortem stability of SARS-CoV-2 in nasopharyngeal mucosa
  publication-title: Emerg Infect Dis
– volume: 58
  start-page: e01094
  year: 2020
  ident: bib0019
  article-title: Stability of SARS-CoV-2 in phosphate-buffered saline for molecular detection
  publication-title: J Clin Microbiol
– volume: 5
  year: 2020
  ident: bib0017
  article-title: Safe management of bodies of deceased persons with suspected or confirmed COVID-19: a rapid systematic review
  publication-title: BMJ Glob Health
– volume: 11
  start-page: 19342
  year: 2021
  ident: bib0004
  article-title: Prospective postmortem evaluation of 735 consecutive SARS-CoV-2-associated death cases
  publication-title: Sci Rep
– reference: World Health Organization. Infection prevention and control for the safe management of a dead body in the context of COVID-19: interim guidance,
– volume: 106
  start-page: 1
  year: 2021
  end-page: 2
  ident: bib0005
  article-title: How long can SARS-CoV-2 persist in human corpses?
  publication-title: Int J Infect Dis
– volume: 73
  year: 2020
  ident: bib0020
  article-title: Review: the safe handling of a corpse (suspected) with COVID-19
  publication-title: J Forensic Leg Med
– volume: 112
  start-page: 64
  year: 2020
  end-page: 77
  ident: bib0016
  article-title: Management of the corpse with suspect, probable or confirmed COVID-19 respiratory infection - Italian interim recommendations for personnel potentially exposed to material from corpses, including body fluids, in morgue structures and during autopsy practice
  publication-title: Pathologica
– volume: 17
  start-page: 411
  year: 2021
  end-page: 418
  ident: bib0006
  article-title: The handling of SARS-CoV-2 associated deaths - infectivity of the body
  publication-title: Forensic Sci Med Pathol
– volume: 17
  start-page: 403
  year: 2021
  end-page: 410
  ident: bib0018
  article-title: Post-mortem persistence of SARS-CoV-2: a preliminary study
  publication-title: Forensic Sci Med Pathol
– volume: 43
  start-page: 215
  year: 2022
  end-page: 219
  ident: bib0002
  article-title: How Long Can a dead body remain infectious?: postmortem nasopharyngeal swabs and SARS-CoV-2 culture in a corpse over an 87-day period
  publication-title: Am J Forensic Med Pathol
– volume: 28
  start-page: 244
  year: 2022
  end-page: 247
  ident: bib0010
  article-title: Postmortem antigen-detecting rapid diagnostic tests to predict infectivity of SARS-CoV-2-Associated deaths
  publication-title: Emerg Infect Dis
– volume: 8
  start-page: 24
  year: 2022
  end-page: 31
  ident: bib0001
  article-title: Postmortem nasopharyngeal swabs performed during the COVID-19 infection: analysis of preliminary clinical records by the Genoa institute of legal medicine (North-West Italy)
  publication-title: J Forensic Sci Med
– volume: 73
  start-page: 304
  year: 2020
  end-page: 307
  ident: bib0012
  article-title: Development of genetic diagnostic methods for detection for novel coronavirus 2019(nCoV-2019) in Japan
  publication-title: Jpn J Infect Dis
– reference: Centers for Disease Control and Prevention. Collection and submission of postmortem specimens from deceased persons with confirmed or suspected COVID-19, postmortem guidance,
– volume: 27
  start-page: 1734
  year: 2021
  end-page: 1737
  ident: bib0009
  article-title: Rapid antigen test for postmortem evaluation of SARS-CoV-2 carriage
  publication-title: Emerg Infect Dis
– volume: 26
  start-page: 2157
  year: 2020
  end-page: 2161
  ident: bib0011
  article-title: Clinicopathologic and immunohistochemical findings from autopsy of patient with COVID-19
  publication-title: Japan. Emerg Infect Dis
– reference: ; 2020 [accessed 27 September 2022].
– volume: 17
  start-page: 411
  year: 2021
  ident: 10.1016/j.ijid.2023.01.046_bib0006
  article-title: The handling of SARS-CoV-2 associated deaths - infectivity of the body
  publication-title: Forensic Sci Med Pathol
  doi: 10.1007/s12024-021-00379-9
– volume: 58
  start-page: e01094
  year: 2020
  ident: 10.1016/j.ijid.2023.01.046_bib0019
  article-title: Stability of SARS-CoV-2 in phosphate-buffered saline for molecular detection
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.01094-20
– volume: 27
  start-page: 329
  year: 2021
  ident: 10.1016/j.ijid.2023.01.046_bib0007
  article-title: Postmortem stability of SARS-CoV-2 in nasopharyngeal mucosa
  publication-title: Emerg Infect Dis
  doi: 10.3201/eid2701.203112
– volume: 27
  start-page: 1734
  year: 2021
  ident: 10.1016/j.ijid.2023.01.046_bib0009
  article-title: Rapid antigen test for postmortem evaluation of SARS-CoV-2 carriage
  publication-title: Emerg Infect Dis
  doi: 10.3201/eid2706.210226
– volume: 28
  start-page: 244
  year: 2022
  ident: 10.1016/j.ijid.2023.01.046_bib0010
  article-title: Postmortem antigen-detecting rapid diagnostic tests to predict infectivity of SARS-CoV-2-Associated deaths
  publication-title: Emerg Infect Dis
  doi: 10.3201/eid2801.211749
– volume: 11
  start-page: 19342
  year: 2021
  ident: 10.1016/j.ijid.2023.01.046_bib0004
  article-title: Prospective postmortem evaluation of 735 consecutive SARS-CoV-2-associated death cases
  publication-title: Sci Rep
  doi: 10.1038/s41598-021-98499-3
– volume: 73
  year: 2020
  ident: 10.1016/j.ijid.2023.01.046_bib0020
  article-title: Review: the safe handling of a corpse (suspected) with COVID-19
  publication-title: J Forensic Leg Med
  doi: 10.1016/j.jflm.2020.101999
– volume: 112
  start-page: 64
  year: 2020
  ident: 10.1016/j.ijid.2023.01.046_bib0016
  publication-title: Pathologica
– ident: 10.1016/j.ijid.2023.01.046_bib0021
– volume: 43
  start-page: 215
  year: 2022
  ident: 10.1016/j.ijid.2023.01.046_bib0002
  article-title: How Long Can a dead body remain infectious?: postmortem nasopharyngeal swabs and SARS-CoV-2 culture in a corpse over an 87-day period
  publication-title: Am J Forensic Med Pathol
  doi: 10.1097/PAF.0000000000000779
– volume: 106
  start-page: 1
  year: 2021
  ident: 10.1016/j.ijid.2023.01.046_bib0005
  article-title: How long can SARS-CoV-2 persist in human corpses?
  publication-title: Int J Infect Dis
  doi: 10.1016/j.ijid.2021.03.052
– ident: 10.1016/j.ijid.2023.01.046_bib0022
– volume: 73
  start-page: 304
  year: 2020
  ident: 10.1016/j.ijid.2023.01.046_bib0012
  article-title: Development of genetic diagnostic methods for detection for novel coronavirus 2019(nCoV-2019) in Japan
  publication-title: Jpn J Infect Dis
  doi: 10.7883/yoken.JJID.2020.061
– volume: 5
  year: 2020
  ident: 10.1016/j.ijid.2023.01.046_bib0017
  article-title: Safe management of bodies of deceased persons with suspected or confirmed COVID-19: a rapid systematic review
  publication-title: BMJ Glob Health
  doi: 10.1136/bmjgh-2020-002650
– volume: 135
  start-page: 2055
  year: 2021
  ident: 10.1016/j.ijid.2023.01.046_bib0008
  article-title: Infectivity of deceased COVID-19 patients
  publication-title: Int J Legal Med
  doi: 10.1007/s00414-021-02546-7
– volume: 17
  start-page: 403
  year: 2021
  ident: 10.1016/j.ijid.2023.01.046_bib0018
  article-title: Post-mortem persistence of SARS-CoV-2: a preliminary study
  publication-title: Forensic Sci Med Pathol
  doi: 10.1007/s12024-021-00375-z
– volume: 26
  start-page: 2157
  year: 2020
  ident: 10.1016/j.ijid.2023.01.046_bib0011
  article-title: Clinicopathologic and immunohistochemical findings from autopsy of patient with COVID-19
  publication-title: Japan. Emerg Infect Dis
  doi: 10.3201/eid2609.201353
– volume: 8
  start-page: 24
  year: 2022
  ident: 10.1016/j.ijid.2023.01.046_bib0001
  article-title: Postmortem nasopharyngeal swabs performed during the COVID-19 infection: analysis of preliminary clinical records by the Genoa institute of legal medicine (North-West Italy)
  publication-title: J Forensic Sci Med
  doi: 10.4103/jfsm.jfsm_5_21
– volume: 83
  start-page: 322
  year: 2011
  ident: 10.1016/j.ijid.2023.01.046_bib0013
  article-title: A novel real-time PCR system for simultaneous detection of human viruses in clinical samples from patients with uncertain diagnoses
  publication-title: J Med Virol
  doi: 10.1002/jmv.21962
– volume: 117
  start-page: 7001
  year: 2020
  ident: 10.1016/j.ijid.2023.01.046_bib0014
  article-title: Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.2002589117
– volume: 136
  start-page: 935
  year: 2022
  ident: 10.1016/j.ijid.2023.01.046_bib0015
  article-title: SARS-CoV-2 viral load and replication in postmortem examinations
  publication-title: Int J Legal Med
  doi: 10.1007/s00414-021-02753-2
– volume: 10
  start-page: e60361
  year: 2021
  ident: 10.1016/j.ijid.2023.01.046_bib0003
  article-title: Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage
  publication-title: eLife
  doi: 10.7554/eLife.60361
SSID ssj0004668
Score 2.3753102
Snippet •Infectious SARS-CoV-2 remained in 55% (6/11) corpses and 43% (13/30) specimens.•The highest infectious titer was 2.09E + 06 plaque-forming units/g in corpse...
The prolonged presence of infectious SARS-CoV-2 in deceased patients with COVID-19 has been reported. However, infectious virus titers have not been...
Objectives: The prolonged presence of infectious SARS-CoV-2 in deceased patients with COVID-19 has been reported. However, infectious virus titers have not...
SourceID doaj
proquest
pubmed
crossref
elsevier
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 103
SubjectTerms Autopsy
Cadaver
Communicable Diseases
COVID-19
COVID-19 - diagnosis
COVID-19 Testing
Humans
Infectious titer
Lung
Postmortem interval
SARS-CoV-2
Virus isolation
SummonAdditionalLinks – databaseName: DOAJ: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlh1IIpd226TZpUaG3IrD1sKxjsm3YFNJC8yA3YY8k2BB2l-zm_2fGsk1yaHLp1Ui2NBp5vhnNfGLsG2LWKBsdhG4UOihVY0WjqBDYhdaE2skqUmjg9Hc1v9C_rszVg6u-KCcs0wNnwVGUV8kIlO0YtaqhgQTB1AA61camjucTbd7gTI0VkbkIDs2bcLaUfblMzuxaXC-II1SqjrCToO8Dk9Qx9z-yTP9Cnp0FOn7DXvfQkR_mIb9lL-Jywl6e9ofjE7abQ3A8Vxa9YyeUw8E73uQNXyU-5F3dbfjZ4d8zMVtdColPOTqg603s2vQ0qxtO8Vk--3N58kOU7j27OP55PpuL_uYEAaa0WxEqa52DJpoioQdVFzKEZForAVyhXLIOgQ04F3SRKtskxAFQtQZCCegxJKM-sJ3lahk_Mu5MSLqMsjIJdDS1syj-UOvQFrgW4KasHITnoacVp9stbvyQP3btSeCeBO6L0qPAp-z72GedSTWebH1EazK2JELs7gGqie_VxD-nJlOmhhX1Q80p_iXxRYsnP23GXj0iyUjj2X5fB6XxuF3pDKZZRlxfLy3R_SAoqqdsL2vTODFV0XXE0n36HxPeZ69oQDnJ6IDtbG_v4mfET9v2S7dV7gHWYROH
  priority: 102
  providerName: Directory of Open Access Journals
Title High titers of infectious SARS-CoV-2 in corpses of patients with COVID-19
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1201971223000474
https://dx.doi.org/10.1016/j.ijid.2023.01.046
https://www.ncbi.nlm.nih.gov/pubmed/36754229
https://www.proquest.com/docview/2774896618
https://doaj.org/article/ea332ec2822e438cacfcd58cc4f857f3
Volume 129
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBYhh1IoJU1f27RBhd6Ku7YelnVMNg3ZlrTQbcLehKxHcCi7S3Zz7W_vjCUvyaEp9GKwGNnyaKz5JM18IuQDYNbArPCFsBwmKLVVheWYCKx9K32jWR1waeD8W312Ib7M5XyHTIZcGAyrzGN_GtP70TqXjLM2x6uuG88q8F1aVeDfEJgo5AQVQqGVf_pd3cmNTOlwIFygdE6cSTFe3XWHbKGM99SdCILvOKeew_-ej_obBu190ekeeZpBJD1K7XxGdsJinzw6z9vk--RJWoyjKcfoOZliNAftGZTXdBnpEIF1u6azox-zYrK8LBiUUpiKrtahl8mEq2uKK7V08v1yelJU-gW5OP38c3JW5DMUCicrtSl8rZTWzgZZRphLNSXzPspWMed0yXVUGiCO09qLMtbKRkAErm6l85WDuUOU_CXZXSwX4TWhWvooqsBqGZ0IstHKeehO4dvSWXjciFSD8ozLBON4zsUvM0SSXRtUuEGFm7IyoPAR-bits0r0Gg9KH2OfbCWRGrsvWN5cmWwbJljOWXAYHhsEb6BpEdrZOCdiI1XkI8KHHjVD9imMl_Cg7sFXy22te_b5z3rvB6Mx8OPiboxdBOhfwxQS_wA8akbkVbKm7YfxGg8mZvrNf771gDzGuxRh9Jbsbm5uwzsAT5v2sP874Hoy_XrYL0DAdTo__gMoTBV7
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3JbtNAdFQVCZAQgrKlbIMEJ2Riz-LxHDiUlCqhTZFIW_U2tWdBrqokalIhLvwUP8h79jhqDxQJqdfxbH7vzVtm3kLIW9BZPSuFS0TJwUDJS5WUHAOBtaukKzTLPV4NjPfz4aH4ciyP18jvLhYG3Soj7295esOtY0s_QrM_r-v-JAPZpVUG8g0VEyWiZ-Wu__kD7LbFx9E2IPkdYzufDwbDJJYWSKzM1DJxuVJa29LLNICJUaTMuSArxazVKddBaZD8Vmsn0pCrMoCgtHklrcssqNQBS0UA378lgF1g2YQPv7JLwZht_B3sLsHtxUid1qmsPq0xPSnjTa5Q1LovScOmaMAVofg3pbcRfjsPyP2otdKtFjAPyZqfbpDb4_guv0Hutbd_tA1qekRG6D5Cm5TNCzoLtHP5uljQyda3STKYHSUMWinYvvOFb_rEDK8LilfDdPD1aLSdZPoxObwRyD4h69PZ1D8jVEsXROZZLoMVXhZaWQf0I1yV2hKm65GsA56xMaM5FtY4M53r2qlBgBsEuEkzAwDvkferMfM2n8e1vT8hTlY9MRd30zA7_24iMRpfcs68RX9cL3gBWwuwz8JaEQqpAu8R3mHUdOGuwKBhovrapeVq1JUD8c9xbzqiMcAp8PmnnHrAr2EKMw2BPlb0yNOWmlY_xnOshMz05n-u-prcGR6M98zeaH_3ObmLX1r3phdkfXl-4V-C5rasXjUnhZKTmz6afwDFsk9H
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High+titers+of+infectious+SARS-CoV-2+in+corpses+of+patients+with+COVID-19&rft.jtitle=International+journal+of+infectious+diseases&rft.au=Saitoh%2C+Hisako&rft.au=Sakai-Tagawa%2C+Yuko&rft.au=Nagasawa%2C+Sayaka&rft.au=Torimitsu%2C+Suguru&rft.date=2023-04-01&rft.pub=Elsevier+Ltd&rft.issn=1201-9712&rft.eissn=1878-3511&rft.volume=129&rft.spage=103&rft.epage=109&rft_id=info:doi/10.1016%2Fj.ijid.2023.01.046&rft.externalDocID=S1201971223000474
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1201-9712&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1201-9712&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1201-9712&client=summon